Does INCLISIRAN Cause Disease progression? 11 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Disease progression have been filed in association with INCLISIRAN (LEQVIO). This represents 0.2% of all adverse event reports for INCLISIRAN.
11
Reports of Disease progression with INCLISIRAN
0.2%
of all INCLISIRAN reports
1
Deaths
8
Hospitalizations
How Dangerous Is Disease progression From INCLISIRAN?
Of the 11 reports, 1 (9.1%) resulted in death, 8 (72.7%) required hospitalization, and 5 (45.5%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INCLISIRAN. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does INCLISIRAN Cause?
Arthralgia (689)
Myalgia (518)
Injection site pain (488)
Low density lipoprotein increased (423)
Pain in extremity (417)
Pain (342)
Fatigue (325)
Drug ineffective (318)
Diarrhoea (309)
Dyspnoea (297)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which INCLISIRAN Alternatives Have Lower Disease progression Risk?
INCLISIRAN vs INCOBOTULINUMTOXINA
INCLISIRAN vs INDACATEROL
INCLISIRAN vs INDAPAMIDE
INCLISIRAN vs INDAPAMIDE\PERINDOPRIL
INCLISIRAN vs INDAPAMIDE\PERINDOPRIL ARGININE